In contrast with the data reported in the human disease, tumor growth was reduced in a transplantable mouse model of pancreatic cancer, where transgenic mice overexpressing TSLP in the skin (K14-TSLPtg) were subcutaneously injected with syngenic pancreatic cancer cells, compared to the wild-type (WT) controls (30). This evidence concerns the gene KRT14 and pancreatic neoplasm.